WASHINGTON — The government on Thursday unveiled a new program to cut prescription drug costs for Medicaid patients by tying prices to those paid in other countries. The announcement follows previous ...
Delcath Systems (NASDAQ:DCTH) traded higher in the premarket on Thursday after the MedTech issued its full-year revenue outlook and disclosed plans to widen market access by entering into a Medicaid ...
The Trump administration’s plan to lower US drug costs through two new pricing models is prompting legal concerns from the ...
On December 19, 2025, the Centers for Medicare & Medicaid Services (CMS) released GLOBE (Global Benchmark for Efficient Drug Pricing Model) and GUARD (Guarding U.S. Medicare Against Rising Drug Costs) ...
The Centers for Medicare and Medicaid Services has issued a proposed rule to drive down prescription drug costs in Medicaid by increasing price transparency. The rule would allow CMS to have more ...
(In January 7 story, corrects name of Rick Pollack in paragraph 5) By Nate Raymond BOSTON, Jan 7 (Reuters) - The Trump administration cannot require hospitals serving low-income Americans to pay full ...
Throughout 2025, Congress introduced several bills related to the pharmacy benefit management (PBM) industry. As with the 118th Congress in 2024 ...
Unfortunately, the Trump administration has proposed a cure that’s worse than the disease. It’s called “most-favored nation,” ...
Fluticasone Propionate, an authorized generic version of asthma medication Flovent, sits on a table in nasal spray form. (Photo by _bubby_, CC BY 2.0, via Courthouse News) PHOENIX (CN) — A federal ...
Medicaid is doing a novel payment system for the new, promising and expensive sickle cell treatment. It may become a model ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results